Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01341678 · ClinicalTrials.gov registry record · NA

Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease

A NA study of Chronic Kidney Disease, sponsored by Geoffrey Block.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT01341678: Completed NA study of Chronic Kidney Disease, sponsored by Geoffrey Block.

NCT01341678 is a NA study of Chronic Kidney Disease that has completed, run by Geoffrey Block. The registered enrollment target is 15 participants, below the 3,207-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01341678, a NA study of Chronic Kidney Disease, has completed, sponsored by Geoffrey Block.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to describe the circadian rhythm of serum and salivary phosphorus in patients with chronic kidney disease and determine its' modification in response to changes in dietary phosphate load.

Primary Outcome

After 1 week of a controlled phosphorus diet patients will be hospitalized for 24 hours and serum phosphorus will be obtained every 4 hours. After a 4 day washout, each subject will cross over to a low phosphorus diet (for 1 week) followed by a 4 day washout and cross over to a high phosphorus diet for 1 week. At the end of each weekly diet a 24 hour hospitalization will occur with samples collected every 4 hours.

Conditions Studied

Chronic Kidney Disease

Interventions

  • OTHER Diet Only
  • DRUG Lanthanum Carbonate
  • DIETARY_SUPPLEMENT NeutraPhos

Study Locations (1)

Colorado

  • Denver Nephrologists, PC - Denver

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2011-04
Est. Completion 2011-10
Phase NA
Geoffrey Block

1 total trials

What the finished NCT01341678 record still lists

NCT01341678 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 3,207-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Chronic Kidney Disease appearing as the primary indexed condition, and to 3 interventions - of which Diet Only is the first listed.

NCT01341678 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT01341678 about?

NCT01341678 is a clinical study titled "Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease". The purpose of this study is to describe the circadian rhythm of serum and salivary phosphorus in patients with chronic kidney disease and determine its' modification in response to changes in dietary phosphate load.

What is the current status of trial NCT01341678?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2011-04. Estimated completion is 2011-10.

What conditions does trial NCT01341678 study?

This clinical trial studies the following conditions: Chronic Kidney Disease.

What interventions are being tested in trial NCT01341678?

The interventions under investigation include: Diet Only (OTHER), Lanthanum Carbonate (DRUG), NeutraPhos (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01341678?

This trial is sponsored by Geoffrey Block, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01341678 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01341678's enrollment target sits among peer trials

15 94th of 101 higher than 6 of 101 other Chronic Kidney Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01341678, the US trial registry maintained by the National Library of Medicine. NCT01341678 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.